Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 6.32
+0.72 (12.86%)
At close: Dec 30, 2025
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €176.96 million as of December 30, 2025. Its market cap has increased by 7.48% in one year.
Market Cap
176.96M
Enterprise Value
159.49M
Revenue
8.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.32
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 176.96M, a decrease of -27.68%. That is a compound annual growth rate of -5.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 156.80M | -14.37% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | 245.41M | 0.29% |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 44.74B |
| argenx SE | 43.98B |
| Financière de Tubize | 9.30B |
| Fagron NV | 1.56B |
| Ion Beam Applications | 355.30M |
| Onward Medical | 187.90M |
| Nyxoah | 175.12M |
| Sequana Medical NV | 39.44M |